Andrew J. Einhorn Insider Trading
Get free email notifications about insider trading for Andrew J. Einhorn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Andrew J. Einhorn. Andrew J. Einhorn is a Chief Financial Officer in Edge Therapeutics, Inc. ($EDGE) and a Chief Financial Officer in Osmotica Pharmaceuticals plc ($OSMT).
Address: C/O MYOS CORPORATION 45 HORSEHILL ROAD, SUITE 106 CEDAR KNOLLS 07927 NJ
Companies in which Andrew J. Einhorn is an Insider
Osmotica Pharmaceuticals plc
Trading Symbol: OSMTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Andrew J. Einhorn: Chief Financial Officer
Holdings: 157,547 shares
Latest Transaction: Jan 26 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PDS Biotechnology Corp
Trading Symbol: EDGEIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Andrew J. Einhorn: Chief Financial Officer
Holdings: 43,223 shares
Current Value: $412,780
Latest Transaction: Mar 13 2017
$EDGE Market Capitalization: $272.98M
$EDGE Previous Close: $9.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Andrew J. Einhorn
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 26 2021 | OSMT | Osmotica Pharmaceu ... | Einhorn Andrew J. | Chief Financial Off ... | Payment of Exercise | F | 4.46 | 9,668 | 43,119 | 157,547 | 167.2 K to 157.5 K (-5.78 %) |
May 20 2020 | OSMT | Osmotica Pharmaceu ... | Einhorn Andrew J. | Chief Financial Off ... | Option Exercise | A | 0.00 | 71,550 | 0 | 71,550 | |
May 20 2020 | OSMT | Osmotica Pharmaceu ... | Einhorn Andrew J. | Chief Financial Off ... | Grant | A | 0.00 | 71,550 | 0 | 167,215 | 95.7 K to 167.2 K (+74.79 %) |
Jan 30 2020 | OSMT | Osmotica Pharmaceu ... | Einhorn Andrew J. | Chief Financial Off ... | Payment of Exercise | F | 7.00 | 9,184 | 64,288 | 95,665 | 104.8 K to 95.7 K (-8.76 %) |
Jan 28 2019 | OSMT | Osmotica Pharmaceu ... | Einhorn Andrew J. | Chief Financial Off ... | Grant | A | 0.00 | 104,849 | 0 | 104,849 | 0 to 104.8 K |
Mar 13 2017 | EDGE | Edge Therapeutics, ... | Einhorn Andrew J. | Chief Financial Off ... | Option Exercise | X | 2.39 | 1,567 | 3,745 | 0 | |
Mar 13 2017 | EDGE | Edge Therapeutics, ... | Einhorn Andrew J. | Chief Financial Off ... | Buy | X | 2.39 | 1,567 | 3,745 | 43,223 | 41.7 K to 43.2 K (+3.76 %) |